聯(lián)系電話
上海允麥生物科技有限公司
中級會(huì)員·7年
- 聯(lián)系人：
- 麥經(jīng)理
- 電話：
- 86-021-34553900
- 手機(jī)：
- 15121004110
- 傳真：
- 86-021-34553900
- 地址：
- 上海市青浦區(qū)
- 個(gè)性化：
- www.shymbio.com
- 網(wǎng)址：
- www.shymbio.com
掃一掃訪問手機(jī)商鋪
 提 供 商 |
上海允麥生物科技有限公司 |  資料大小 |
31.5KB |
|---|---|---|---|
 資料類型 |
JPG 圖片 |  資料圖片 |
|
 下載次數(shù) |
0次 |  瀏覽次數(shù) |
108次 |
Recombinant human VHLH
pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.
濃度：1mg/ ml
來源：Recombinant Human
純度：≥95% SDS-PAGE
表達(dá)系統(tǒng)：Escherichia coli
標(biāo)簽：His tag
蛋白長度：Full length protein
內(nèi)毒素水平：<1.000 Eu/µg
純化方法：HPLC
應(yīng)用：SDS-PAGE，Western blot，ELISA
Biological activity,immunology research
保存：-20℃
保質(zhì)期：1年
Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases.
產(chǎn)品名稱：Rabbit Anti-VHLH antibody
Rabbit Anti-VHLH
別名：pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.
來源：Rabbit
克隆類型：Polyclonal
濃度：1mg/ml
亞型：IgG
應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500
反應(yīng):Human
免疫原：KLH conjugated synthetic peptide derived from human VHLH
保存：-20℃
保質(zhì)期：1年
單克隆抗體
產(chǎn)品名稱：Anti-VHLH antibody
Mouse Anti-VHLH
別名：pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.
來源：Mouse
克隆類型：Monoclonal
濃度：1mg/ml
亞型：IgG
應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500
反應(yīng): Human
免疫原：KLH conjugated synthetic peptide derived from human VHLH
保存：-20℃
保質(zhì)期：1年
Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases.
